BioCentury
ARTICLE | Clinical News

Cellvizio regulatory update

January 14, 2013 8:00 AM UTC

Mauna Kea said the Centers for Medicare and Medicaid Services (CMS) approved a reimbursement rate of $520 for the use of Cellvizio optical biopsy device during endoscopy procedures in the upper GI tra...